The effect of bovine serum albumin-glutaraldehyde and polyethylene glycol polymer on neointimal hyperplasia in rabbit carotid artery anastomosis

Abstract

Objective

Since the systemic drugs have been used to reduce the hyperplasic response in the tunica intima, the periadventitial local drug applications to the vascular wall have gained more popularity. In this study, we investigated the effect of bovine serum albumin-glutaraldehyde and polyethylene glycol polymer on neointimal hyperplasia in rabbit carotid artery anastomosis to explore the effects of these two different agents.

Methods

21 New Zealand male rabbits were randomly divided into three groups. The carotid artery transection and anastomosis was performed onthe control group. The bovine serum albumin-glutaraldehyde and the polyethylene glycol polymer were applied locally on the other two groups seperatley after transection and anastomosis of the carotid arteries. At the end of 28-day follow-up, the histological and the immunohistochemical results related to neointimal hyperplasia were compared.

Results

The glue residues were detected in the BSA-glutaraldehyde group, but in the PEG polymer group there was no glue residue. The intima thickness and the intima/media thickness ratio in the control group was significantly higher (p<0.05) than the other groups. These values did not differ significantly between the BSA-glutaraldehyde group and the PEG polymer group (p>0.05). The lumen diameter and the area in the control group were significantly higher (p < 0.05) than the BSA-glutaraldehyde group. These values between the control group and the PEG polymer group did not differ significantly (p>0.05). aSMA-positive staining score in the Control group was found to be significantly lower (p < 0.05) than the BSA-glutaraldehyde and PEG polymer group and the VEGF-positive staining score in the control group was found to be significantly higher (p < 0.05) than the BSA-glutaraldehyde and the PEG polymer group.

Conclusions

Although the both agents have positive results on neointimal hyperplasia, it would be favorable to use polyethylene glycol polymer, since it does not seem to affect the lumen area and the lumen diameter of the vessel.

Keywords

Bovin serum albumin glue hemostatic neointimal hyperplasia polyethylene glycol tissue

Get full access to this article

View all access options for this article.

References

Galt

Zwolak

Wagner

, et al. Differential response of arteries and vein grafts to blood flow reduction. J Vascular Surg 1993; 17: 563–570.

Zarins

Bassiouny

, et al. Intimal hyperplasia. In: Hollier LH, Strandness DE, Towne JB et al. (eds) Haimovici?s Vascular Surgery. 5th ed. New Jersey: Wiley Publishers, 2004, pp.165--167

Chaudhary

Guo

Shi

, et al. Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery. J Control Release 2016; 233: 174–180.

Cooley

Frazier

The past 50 years of cardiovascular surgery. Circulation 2000; 102: Iv-87–Iv-93.

Minato

Katayama

Yunoki

, et al. Hemostatic effectiveness of a new application method for fibrin glue, the “rub-and-spray method”, in emergency aortic surgery for acute aortic dissection. Ann Thorac Cardiovasc Surg 2009; 15: 265–271.

Spotnitz

WD.

Hemostats, sealants, and adhesives: a practical guide for the surgeon. Am Surg 2012; 78: 1305–1321.

Vyas

Saha

SP.

Comparison of hemostatic agents used in vascular surgery. Expert Opin Biol Ther 2013; 13: 1663–1672.

I. C. IFU for BioGlue Surgical Adhesive 2019, www.cryolife.com/wp-content/uploads/2019/08/L6312.010_IFU_BioGlue_Syringe.pdf (accessed 1 December 2019).

Hill

Estridge

Maroney

, et al. Treatment of suture line bleeding with a novel synthetic surgical sealant in a canine iliac PTFE graft model. J Biomed Mater Res 2001; 58: 308–312.

10.

Sealant

CS.

Instructions for use. Baxter Healthcare Revision 2009: 3.

11.

Slezak

Klang

Ferguson

, et al. Tissue reactions to polyethylene glycol and glutaraldehyde-based surgical sealants in a rabbit aorta model. J Biomater Appl 2020; 34: 1330–1340.

12.

Byrom

Bannon

White

, et al. Animal models for the assessment of novel vascular conduits. J Vasc Surg 2010; 52: 176–195.

13.

Lan

Zhu

, et al. Establishment of an animal model of vascular restenosis with bilateral carotid artery grafting. Medical Science Monitor: Int Med J Exp Clin Res 2014; 20: 2846.

14.

Kim

Kwon

T-W

Cho

Y-P

, et al. Effect of anastomotic method on intimal hyperplasia in rabbit aorta. J Korean Surg Soc 2010; 79: 377–385.

15.

Tozzi

Hayoz

Ruchat

, et al. Animal model to compare the effects of suture technique on cross-sectional compliance on end-to-side anastomoses. Eur J Cardio-Thoracic Surg 2001; 19: 477–481.

16.

Chen

Wong

Campagnolo

, et al. Adventitial stem cells in vein grafts display multilineage potential that contributes to neointimal formation. Arterioscler Thromb Vasc Biol 2013; 33: 1844–1851.

17.

Tigerstedt

N-M

Savolainen-Peltonen

Lehti

, et al. Vascular cell kinetics in response to intimal injury ex vivo. J Vasc Res 2010; 47: 35–44.

18.

Miyake

Aoki

Morishita

Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFκB and E2F in a rabbit model. Cardiovasc Res 2008; 79: 706–714.

19.

Rutty

Underwood

, et al. A time sequence of vessel wall changes in an experimental model of angioplasty. J Pathol 1994; 172: 287–292.

20.

Takiguchi

Nagano

Ikeda

, et al. Early administration of YT-146, an adenosine A2 receptor agonist, inhibits neointimal thickening after rat femoral artery endothelium injury. Eur J Pharmacol 1995; 281: 205–207.

21.

Asada

Kisanuki

Tsuneyoshi

, et al. Effects of inflation pressure of balloon catheter on vascular injuries and subsequent development of intimai hyperplasia in rabbit aorta. Atherosclerosis 1996; 121: 45–53.

22.

Sullivan

Karas

Aronovitz

, et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995; 96: 2482–2488.

23.

Guzeloglu

Aykut

Albayrak

, et al. Effect of tadalafil on neointimal hyperplasia in a rabbit carotid artery anastomosis model. Ann Thorac Cardiovasc Surg 2013; 19: 468–02017.

24.

Güzeloğlu

Gül

Reel

, et al. The effects of zoledronic acid on neointimal hyperplasia: a rabbit carotid anastomosis model. Anatolian J Cardiol/Anadolu Kardiyoloji Dergisi 2011; 11: 93--100.

25.

Guzeloglu

Reel

Atmaca

, et al. The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model. J Cardiothorac Surg 2012; 7: 57.

26.

Kavala

Kuserli

Turkyilmaz

Effect of N-acetylcysteine on intimal hyperplasia and endothelial proliferation in rabbit carotid artery anastomosis. Arch Med Sci 2019; 15: 1576–1581.

27.

Sürer

Toktas

, et al. Effect of the P2Y12 antagonist ticagrelor on neointimal hyperplasia in a rabbit carotid anastomosis model. Interact Cardiovasc Thorac Surg 2014; 19: 198–204.

28.

X-D

Hong

M-N

Chen

, et al. Adventitial fibroblast-derived vascular endothelial growth factor promotes vasa vasorum-associated neointima formation and macrophage recruitment. Cardiovasc Res 2020; 116: 708–720.

29.

Zhou

Cao

, et al. Effects of tongxinluo on angiogenesis in the carotid adventitia of hyperlipidemic rabbits. Mol Med Rep 2016; 14: 3832–3840.

30.

Chen

DeWispelaere

Dastvan

, et al. Smooth muscle-alpha actin inhibits vascular smooth muscle cell proliferation and migration by inhibiting Rac1 activity. PLoS One 2016; 11: e0155726.

31.

Schachner

Zou

Oberhuber

, et al. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 2004; 77: 1580–1585.

32.

Yan

Peng

, et al. Inhibition of aortic intimal hyperplasia and vascular smooth muscle proliferation and extracellular matrix protein expressions by astragalus–angelica combination. Evid Based Complement Alternat Med 2018; 2018: 1508637.

33.

Johnson

Wilgus

TA.

Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Adv Wound Care (New Rochelle) 2014; 3: 647–661.

34.

Kheirabadi

Field-Ridley

Pearson

, et al. Comparative study of the efficacy of the common topical hemostatic agents with fibrin sealant in a rabbit aortic anastomosis model. Journal of Surgical Research 2002; 106: 99–107.

35.

Azadani

Matthews

, et al. Mechanical properties of surgical glues used in aortic root replacement. Ann Thoracic Surg 2009; 87: 1154–1160.

36.

Murdock

Chang

Luketich

, et al. Cytocompatibility and mechanical properties of surgical sealants for cardiovascular applications. J Thorac Cardiovasc Surg 2019; 157: 176–183.

37.

Wippermann

Konstas

Breuer

, et al. Long-term effects in distal coronary anastomoses using different adhesives in a porcine off-pump model. J Thorac Cardiovasc Surg 2006; 132: 325–331.

38.

Gundry

Black

Izutani

Sutureless coronary artery bypass with biologic glued anastomoses: preliminary in vivo and in vitro results. J Thorac Cardiovasc Surg 2000; 120: 473–477.

39.

Vokrri

Qavdarbasha

Rudari

, et al. Experimental study of sutureless vascular anastomosis with use of glued prosthesis in rabbits. Vascular Health and Risk Management 2015; 11: 211.

40.

Hewitt

Marra

Kann

, et al. BioGlue surgical adhesive for thoracic aortic repair during coagulopathy: efficacy and histopathology. The Annals of Thoracic Surgery 2001; 71: 1609–1612.

41.

Hwang

Kuo

, et al. Pro‐inflammation and pro‐fibrosis factors were highly induction in heart tissues of carotid arteries balloon‐injured animal model. Cell Biochem Funct 2012; 30: 390–394.

42.

Mitrofanova

Orshanskaya

, et al. Histological evidence of inflammatory reaction associated with fibrosis in the atrial and ventricular walls in a case–control study of patients with history of atrial fibrillation. EP Europace 2016; 18: iv156–iv62.

43.

Angelo

Kurzrock

Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res 2007; 13: 2825–2830.

44.

Mathews

Merges

McLeod

, et al. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci 1997; 38: 2729–2741.

45.

Shaik-Dasthagirisaheb

Varvara

Murmura

, et al. Vascular endothelial growth factor (VEGF), mast cells and inflammation. SAGE Publications Sage UK: London, England; 2013.

46.

Shibuya

VEGF-VEGFR system as a target for suppressing inflammation and other diseases. Endocr Metab Immune Disord Drug Targets 2015; 15: 135–144.

47.

Zhang

Fang

, et al. VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes: a cohort study. Medicine (Baltimore) 2018; 97: e0415.

48.

Fürst

Banerjee

Release of glutaraldehyde from an albumin-glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity. Ann Thorac Surg 2005; 79: 1522–1528.

49.

Schiller

Rudorf

Kiderlen

, et al. Short-Term tissue response of lapine carotid artery microanastomoses to BioGlue®. Thorac Cardiovasc Surg 2007; 55: 298–303.

50.

Zilla

Weissenstein

Human

, et al. High glutaraldehyde concentrations mitigate bioprosthetic root calcification in the sheep model. The Annals of Thoracic Surgery 2000; 70: 2091–2095.

51.

Stooker

Niessen

Jansen

, et al. Surgical sealant in the prevention of early vein graft injury in an ex vivo model. Cardiovascular Pathology 2003; 12: 202–206.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.16 MB